Chang Edward I
Department of Plastic Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Arch Plast Surg. 2022 Apr 6;49(2):150-157. doi: 10.1055/s-0042-1744414. eCollection 2022 Mar.
Patients undergoing treatment for breast cancer who undergo an axillary dissection and require adjuvant therapies such as radiation and chemotherapy are at high risk of developing lymphedema of the associated extremity. Historically, patients with lymphedema were treated with ablative procedures aimed simply to remove excess fluid and adiposity; however, the field of lymphatic surgery employing super-microsurgery techniques has witnessed tremendous advances in a relatively short period of time. Advancements in surgical instruments, microscope magnification and optics, imaging technology, and surgeon experience have ushered in a new era of hope to treat patients suffering from breast cancer-related lymphedema (BCRL). Here we aim to present the available options for patients suffering from BCRL, and the pinnacle in reconstruction and restoration for these patients.
接受乳腺癌治疗且进行腋窝淋巴结清扫并需要放疗和化疗等辅助治疗的患者,发生相关肢体淋巴水肿的风险很高。从历史上看,淋巴水肿患者接受的是旨在单纯去除多余液体和脂肪的切除手术;然而,采用超显微手术技术的淋巴外科领域在相对较短的时间内取得了巨大进展。手术器械、显微镜放大倍数和光学、成像技术以及外科医生经验的进步,为治疗乳腺癌相关淋巴水肿(BCRL)患者带来了新的希望时代。在此,我们旨在介绍BCRL患者可用的治疗选择,以及这些患者重建和恢复的巅峰治疗方法。